Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

U.S. agencies examine reports of early COVID-19 infections in Wuhan lab

Published 05/24/2021, 05:27 PM
Updated 05/25/2021, 09:00 AM
© Reuters. FILE PHOTO: The P4 laboratory of Wuhan Institute of Virology is seen behind a fence during the visit by the World Health Organization (WHO) team tasked with investigating the origins of the coronavirus disease (COVID-19), in Wuhan, Hubei province, China

(This May 24 story corrects date in 10th paragraph)

By Mark Hosenball

WASHINGTON (Reuters) - U.S. intelligence agencies are examining reports that researchers at a Chinese virology laboratory were seriously ill in 2019 a month before the first cases of COVID-19 were reported, according to U.S. government sources who cautioned that there is still no proof the disease originated at the lab.

A still-classified U.S. intelligence report circulated during former President Donald Trump's administration alleged that three Wuhan Institute of Virology (WIV) researchers became so ill in November 2019 that they sought hospital care, sources familiar with U.S. intelligence reporting and analysis said, speaking on condition of anonymity.

It remained unclear whether these researchers were hospitalized or what their symptoms were, one of the sources said. The virus first appeared in Wuhan and then spread worldwide.

"We don't have enough information to draw a conclusion about the origins" of the coronavirus, White House Press Secretary Jen Psaki told a news briefing on Monday. "We need data. We need an independent investigation. And that's exactly what we've been calling for."

Information about the researchers was published in the Wall Street Journal on Sunday.

China's foreign ministry spokesman, Zhao Lijian, said on Monday it was "completely untrue" that three WIV staff members had fallen ill.

The origin of the virus is hotly contested. In a report https://www.who.int/health-topics/coronavirus/origins-of-the-virus issued in March written jointly with Chinese scientists, a World Health Organization-led team that spent four weeks in and around Wuhan in January and February said the virus had probably been transmitted from bats to humans through another animal, and that "introduction through a laboratory incident was considered to be an extremely unlikely pathway."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The U.S. intelligence community "hasn't ruled out either theory," one official U.S. source said. Intelligence reporting about possible November infections among Wuhan Institute employees "can't be dismissed" by U.S. researchers, the source added.

The hypothesis that the virus escaped from a Chinese lab has been promoted on some conservative websites, and by some Republicans in the U.S. Congress. U.S. intelligence agencies have not reached their own determination on the cause.

The U.S. State Department published a "fact sheet https://2017-2021.state.gov/fact-sheet-activity-at-the-wuhan-institute-of-virology/index.html" on COVID-19 and the Wuhan lab on Jan. 15, 2021, five days before Trump left office, based in part on information in the classified report, sources said. Trump as president referred to the pathogen as the "China virus" and the "China plague."

The Central Intelligence Agency, National Security Agency and defense intelligence components contributed to both the public fact sheet and classified report, the sources said. Both were assembled by the Office of the Director of National Intelligence.

The classified report is regarded as valid by current U.S. government agencies, experts investigating the origins of COVID-19 and by officials in President Joe Biden's administration.

U.S. agencies are concerned that WHO representatives have been unable to conduct independent investigations inside China into COVID-19's origins, and are therefore wary of WHO findings, one U.S. government source briefed on these investigations said.

"We continue to have serious questions about the earliest days of the COVID-19 pandemic, including its origins within the People's Republic of China," a spokesperson for the White House National Security Council said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In their own report on the origins of COVID-19 issued last week, Republican members of the U.S. House of Representatives intelligence committee asserted that there was "significant circumstantial evidence" suggesting COVID-19 "may have been a leak" from the Wuhan lab.

Such evidence included information indicating "several researchers" at the lab got COVID-19 symptoms in the fall of 2019, the report said.

The WHO, which opened its annual ministerial assembly on Monday, has not announced any follow-up to the Wuhan mission but member states may raise concerns in speeches to the week-long forum. U.S. Health and Human Services Secretary Xavier Becerra is due to address it on Tuesday.

The pandemic has killed more than 3.4 million people worldwide.

Latest comments

totally disillusioned by media reporting standards and integrity.
I still remember that Bloomberg lie about micro spy chip that was thrown out by Apple et al.
Typical CIA/ media trick. First create a lie, then speak as though the lie is truth to further spin the web of deceit.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.